167 related articles for article (PubMed ID: 31145639)
1. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
Kim KH; Kim JY; Yoo JS
Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
[No Abstract] [Full Text] [Related]
2. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
3. Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline.
Cao WQ; Jiang BY; Huang JM; Zhang L; Liu MQ; Yao J; Wu MX; Zhang LJ; Kong SY; Wang Y; Yang PY
Anal Chem; 2019 Oct; 91(19):12435-12443. PubMed ID: 31453685
[TBL] [Abstract][Full Text] [Related]
4. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
5. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
6. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.
Chen R; Tan Y; Wang M; Wang F; Yao Z; Dong L; Ye M; Wang H; Zou H
Mol Cell Proteomics; 2011 Jul; 10(7):M110.006445. PubMed ID: 21474793
[TBL] [Abstract][Full Text] [Related]
7. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques.
Qin X; Chen Q; Sun C; Wang C; Peng Q; Xie L; Liu Y; Li S
Med Oncol; 2013 Mar; 30(1):420. PubMed ID: 23292873
[TBL] [Abstract][Full Text] [Related]
9. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
[TBL] [Abstract][Full Text] [Related]
10. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.
Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment.
Kawakami T; Hoshida Y; Kanai F; Tanaka Y; Tateishi K; Ikenoue T; Obi S; Sato S; Teratani T; Shiina S; Kawabe T; Suzuki T; Hatano N; Taniguchi H; Omata M
Proteomics; 2005 Nov; 5(16):4287-95. PubMed ID: 16254924
[TBL] [Abstract][Full Text] [Related]
12. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
[TBL] [Abstract][Full Text] [Related]
13. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
14. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
[TBL] [Abstract][Full Text] [Related]
15. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
[TBL] [Abstract][Full Text] [Related]
17. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
18. Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.
Shen S; Peng H; Wang Y; Xu M; Lin M; Xie X; Peng B; Kuang M
BMC Cancer; 2018 Jan; 18(1):117. PubMed ID: 29386009
[TBL] [Abstract][Full Text] [Related]
19. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
20. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
